are glp 1 agonists safe Researchers find GLP-1 medications to continue before surgery in patients with diabetes and obesity Concerns have been raised about
Description
Sources for Figure 218
But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.
A New Era in Health?
What to expect
Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent
Its about infrastructure, reporting, transparency, and accountability
